C07C 63/64
Monocyclic acids with unsaturation outside the aromatic ring
C07C63/64 (Monocyclic acids with unsaturation outside the aromatic ring) appears on 17 US grants and 15 published applications in this corpus.
Search patents in C07C- Granted patents
- 17
- Published applications
- 15
- Assignees
- 17
- Inventors
- 49
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 1 | 1 |
| 2023 | 1 | 2 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Aromatic compounds and pharmaceutical uses thereof18 Nov 2025US 12,473,249 B2BASF SE
- Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease2 Jan 2024US 11,858,889 B2The Trustees of Indiana University
- Functionalized dimethoxyphenol monomers and methods for preparing such monomers22 Aug 2023US 11,732,141 B2University of Delaware
- Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease8 Mar 2022US 11,267,780 B2The Trustees of Indiana University
- Polymers prepared from functionalized dimethoxyphenol monomers9 Apr 2019US 10,253,131 B2University of Delaware
- Aromatic compounds and pharmaceutical uses thereof2 Jul 2026US 2026/0184664 A1BASF SE
- Cannabidiolic acid (cbda) derivatives and uses thereof22 Jun 2023US 2023/0192588 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Cannabinoid salt compounds and methods of making same4 May 2023US 2023/0135108 A1Canopy Growth Corporation
- Compound for modulating ddah and adma levels, as well as methods of using thereof to treat disease12 May 2022US 2022/0144795 A1The Trustees of Indiana University
- Aromatic compounds and pharmaceutical uses thereof9 Dec 2021US 2021/0380521 A1BASF SE
Most cited
By later US patents
- Isoprenoid phospholipase A2 inhibitors and preparations comprising same25US 5,141,959 ABristol-Myers Squibb Company · 1992
- RAR selective retinoid agonists13US 6,603,012 B2Hoffmann-La Roche Inc. · 2003
- Leukotriene B.sub.4 synthesis inhibitors9US 5,356,919 AG. D. Searle & Co. · 1994
- Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof5US 7,592,478 B2Galderma Research & Development · 2009
- Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions4US 8,946,224 B2Redx Pharma PLC · 2015